Test Match: Two Anti-Itch Drugs Face OffMay 1, 2025Reducing pruritis is critical to enhancing quality of life for both patients and their people, hence the ongoing search for effective treatments. Ilunocitinib, a recently FDA-approved Janus kinase inhibitor, gave a powerful performance in a head-to-head match-up with Apoquel®.
SPONSORED CONTENTImprove their microbiome, improve quality of lifeWith 70% of a dog’s immune system in the GI tract, you need confidence in their microbiome support — which is why Hill’s developed ActivBiome+. + Learn More
